<DOC>
	<DOCNO>NCT00719680</DOCNO>
	<brief_summary>The purpose study determine whether long-term use new human immunoglobulin G proline ( IgPro ) safe effective treatment primary immunodeficiency .</brief_summary>
	<brief_title>Extension Study Subcutaneous Immunoglobulin Human Patients With Primary Immunodeficiency ( PID )</brief_title>
	<detailed_description />
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<criteria>Subjects primary humoral immunodeficiency participate study ZLB04_009CR ( NCT00419341 ) , namely diagnosis Common Variable Immunodeficiency ( CVID ) define PAGID ( PanAmerican Group Immunodeficiency ) ESID ( European Society Immunodeficiencies ) Xlinked Agammaglobulinemia ( XLA ) define PAGID ESID Women childbearing potential must use agree continue use medically approve contraception must negative pregnancy test screen Written informed consent Ongoing serious bacterial infection time screen Malignancies lymphoid cell lymphocytic leukemia , NonHodgkin 's lymphoma , immunodeficiency thymoma Hypoalbuminemia , proteinlosing enteropathy , proteinuria ( define total urine protein concentration &gt; 0.2 g/L ) Other significant medical condition could increase risk patient Females pregnant , breastfeed plan pregnancy course study A positive result screen follow viral marker : Human immunodeficiency virus ( HIV ) , Hepatitis C virus ( HCV ) Hepatitis B virus ( HBV ) Aspartate aminotransferase ( ASAT ) Alanine aminotransferase ( ALAT ) concentration &gt; 2.5 time Upper Normal Limit ( UNL ) Completion Visit study ZLB04_009CR ( NCT00419341 ) Creatinine concentration &gt; 1.5 time UNL Completion Visit study ZLB04_009CR ( NCT00419341 ) Participation study investigational product IgPro20 within 3 month prior enrollment Evidence uncooperative attitude Any condition likely interfere evaluation study drug satisfactory conduct trial Subjects employee investigational site , relatives spouse investigator</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>CVID</keyword>
	<keyword>XLA</keyword>
</DOC>